EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress

Hui Yin, Hang Lian, Yawen Wang, Luoting Chen, Xueting Liu, Yange Liu

Frontiers in Pharmacology · 20.08.2025 · 16

DOI: 10.3389/fphar.2025.1633519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.08.2025. Verfasst von Hui Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatic fibrosis emerges as a pathological hallmark in the pathogenesis of chronic hepatopathies. Stephania tetrandra S. Moore is a traditional Chinese herb used to treat liver disease. However, the anti-hepatic fibrosis effect of fangchinoline (FAN), an active ingredient of S. tetrandra S. Moore , has not been reported. This study aimed to elucidate the anti-hepatic fibrosis effect of FAN and clarify the underlying molecular mechanisms.

Methods

The DEN-induced hepatic fibrosis mouse model, primary murine hepatic stellate cells (HSCs), and TGF-β-induced activation model of HSCs were used to explore the anti-fibrotic effect of FAN. The proteomics analysis was used to predict the pharmacodynamic mechanisms of FAN, and follow-up validation assays were performed with in vivo and in vitro experiments.

Results

FAN alleviated DEN-induced liver fibrosis in mice, reducing biomarker levels, slowing histopathological changes, and inhibiting collagen deposition. FAN suppressed HSCs activation and the biosynthetic abilities of the extracellular matrix. Proteomics was used to explore the mechanisms of FAN action, which is related to the regulation of taurine metabolism. FAN reversed DEN-induced changes in the levels of taurine and key enzymes that catalyze taurine synthesis. Additional taurine reinforces the regulatory effect of FAN on HSCs activation. Taurine could inhibit oxidative stress. FAN reduced DEN-induced ROS accumulation, which may be associated with Nrf2 pathway activation. Cleaning ROS with N-acetylcysteine enhanced the anti-fibrotic effects of FAN.

Conclusion

FAN can alleviate hepatic fibrosis by regulating taurine metabolism and oxidative stress, which has an important theoretical value.

Schlagwörter

Stichwörter der Autor:innen

fangchinolinehepatic fibrosishepatic stellate cellsoxidative stresstaurine

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital of Shaoyang University, Shaoyang, Hunan, China.

Zitieren

APA

Yin, H., Lian, H., Wang, Y., Chen, L., Liu, X., & Liu, Y. (2025). Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1633519

Vancouver

Yin H, Lian H, Wang Y, Chen L, Liu X, Liu Y. Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1633519

BibTeX
@article{Yin2025,
  author = {Yin, Hui and Lian, Hang and Wang, Yawen and Chen, Luoting and Liu, Xueting and Liu, Yange},
  title = {Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1633519}
}
Kostenlos starten →